Cite
HARVARD Citation
Sands, B. et al. (n.d.). A106 SAFETY OF USTEKINUMAB WITH AND WITHOUT CONCOMITANT CORTICOSTEROIDS OR IMMUNOSUPPRESSANTS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE CROHN'S DISEASE. Journal of the Canadian Association of Gastroenterology. pp. 161-162. [Online].